Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Early research (Phase 1)Ended earlyNCT00003613What this trial is testingO6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell LymphomaWho this might be right forRecurrent Cutaneous T-cell Non-Hodgkin LymphomaStage I Cutaneous T-cell Non-Hodgkin LymphomaStage II Cutaneous T-cell Non-Hodgkin Lymphoma National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT01110135What this trial is testingBendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple MyelomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+26 more University of Washington 43
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Ended earlyNCT01637090What this trial is testingEverolimus in Treating Cutaneous T-cell LymphomaWho this might be right forCutaneous T-Cell Lymphoma Adam Lerner 3
Not applicableStudy completedNCT00079222What this trial is testingVoriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forCancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00131937What this trial is testingSorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaHepatosplenic T-cell Lymphoma+5 more National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00071084What this trial is testingClinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.Who this might be right forCutaneous T-Cell Lymphoma Genmab 22
Early research (Phase 1)Study completedNCT00098332What this trial is testingForodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell LymphomaWho this might be right forLymphoma BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT00103246What this trial is testingPhotodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis FungoidesWho this might be right forLymphomaNon-melanomatous Skin CancerPrecancerous Condition Case Comprehensive Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT00003210What this trial is testingInterleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's DiseaseWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+14 more National Cancer Institute (NCI) 105
Testing effectiveness (Phase 2)Ended earlyNCT00958074What this trial is testingVorinostat in Patients With Primary Cutaneous T-Cell LymphomaWho this might be right forCutaneous T-cell Lymphoma Stage ICutaneous T-cell Lymphoma Stage IICutaneous T-cell Lymphoma Stage III+1 more University of Washington 11
Not applicableStudy completedNCT00445731What this trial is testingA Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forCancer University of Minnesota 115
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00062140What this trial is testingTotal-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01075321What this trial is testingEverolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+16 more Mayo Clinic 58
Testing effectiveness (Phase 2)Ended earlyNCT00004106What this trial is testingTemozolomide in Treating Patients With Mycosis Fungoides or Sezary SyndromeWho this might be right forLymphoma Northwestern University 29
Early research (Phase 1)Study completedNCT00006009What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaWho this might be right forLymphomaSmall Intestine Cancer Stanford University
Testing effectiveness (Phase 2)Study completedNCT00589563What this trial is testingSirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+8 more City of Hope Medical Center 32
Early research (Phase 1)Study completedNCT00004258What this trial is testingEMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Indiana University 40